Skip to content

GE HealthCare Technologies Inc

GEHC

Latest QuantConomy context for GEHC: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
20
Asset profile

GE HealthCare Technologies Inc

GE HealthCare Technologies Inc. is a multinational medical technology company headquartered in Chicago, Illinois. The company, which was spun off from General Electric on January 4, 2023, specializes in medical imaging and information technologies, pharmaceutical diagnostics, and digital solutions. It offers a wide range of products and services, including diagnostic imaging equipment such as CT, MRI, X-ray, and ultrasound devices, as well as patient monitoring systems, anesthesia delivery, and respiratory care solutions. GE HealthCare also provides healthcare IT solutions, including electronic medical records, radiology information systems, and cloud-based products. The company operates globally, with significant presence in over 100 countries, and employs approximately 51,000 people. Its business segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx), and it is known for its innovative use of artificial intelligence, data analytics, and performance improvement services to enhance healthcare delivery.

Symbol
GEHC
Name
GE HealthCare Technologies Inc
Coverage
3 market/data records
Sources
alpaca fmp alphavantage sec nasdaq lse
Latest signal rows

Recent signals for GEHC

Scored rows are pulled from the same signal API used by the digests.

Signal Direction Score Observed Reason
sustained dry up
slightly bullish
62
Jul 1, 02:03 PM GEHC sustained volume dry-up: 10% of expected volume for Wednesday 14:00 UTC, price up 1.97% (strength 62)
uptrend
bullish
39
Jul 1, 02:03 PM GEHC uptrend (gain): price 1.97% (strength 39, current 65.12)
dry up
neutral
13
Jun 30, 07:12 PM GEHC volume dry-up: 24% of expected volume for Tuesday 19:00 UTC, price flat 0.02% (strength 13)

EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).

PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.

Market coverage

Market Exchange Source Asset record
GEHC NASDAQ alpaca GE HealthCare Technologies Inc. Common Stock
GEHC NASDAQ fmp GE HealthCare Technologies Inc.
GEHC NASDAQ alphavantage GE HealthCare Technologies Inc

Recent insider transactions

Buys, last 90d
7
Sells, last 90d
0
Rows
20
Date Insider Role Type Shares Price Value Filing
May 22, 2026 Lobo Kevin Insider purchase 10,000 $64.18 $641,800 4 on EDGAR
May 15, 2026 Rackliffe Philip CEO, AIS grant 16,458 $0.00 $0 4 on EDGAR
May 15, 2026 Bankes Jeannette CEO, Patient Care Solutions other 5,535 $62.67 $346,878 4 on EDGAR
May 12, 2026 Hochman Rodney F Insider purchase 1,618 $62.03 $100,365 4 on EDGAR
May 7, 2026 LESJAK CATHERINE A Insider grant 3,586 $0.00 $0 4 on EDGAR
May 7, 2026 Yang Watkin Phoebe L. Insider grant 3,586 $0.00 $0 4 on EDGAR
May 7, 2026 Lobo Kevin Insider grant 3,586 $0.00 $0 4 on EDGAR
May 7, 2026 Stromberg William J Insider grant 3,586 $0.00 $0 4 on EDGAR
May 7, 2026 Hochman Rodney F Insider grant 3,586 $0.00 $0 4 on EDGAR
May 7, 2026 Madden Anne T Insider grant 3,586 $0.00 $0 4 on EDGAR
May 7, 2026 CULP H LAWRENCE JR Insider grant 3,586 $0.00 $0 4 on EDGAR
May 6, 2026 CULP H LAWRENCE JR Insider purchase 80,805 $61.88 $5,000,076 4 on EDGAR
May 6, 2026 Stromberg William J Insider purchase 1,000 $61.69 $61,689 4 on EDGAR
May 1, 2026 SACCARO JAMES Chief Financial Officer purchase 3,310 $60.60 $200,585 4 on EDGAR
Apr 30, 2026 Jimenez Frank R GC & Corporate Secretary purchase 1,750 $60.45 $105,788 4 on EDGAR
Apr 30, 2026 Arduini Peter J President and CEO purchase 4,169 $59.93 $249,827 4 on EDGAR
Estrampes Catherine Chief Commer. & Growth Officer 3 on EDGAR
Mar 13, 2026 Lobo Kevin Insider grant 777 $0.00 $0 4 on EDGAR
Mar 2, 2026 Kass-Hout Taha Chief Technology Officer grant 13,254 $0.00 $0 4 on EDGAR
Mar 2, 2026 Arduini Peter J President and CEO grant 49,120 $0.00 $0 4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

Query GEHC context like a database.

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.

No spam, no noise. Just the launch and the occasional preview.

More: All insider trades · How to read a Form 4 · API access